Ardea Biosciences Inc. (RDEA) Stock Quote

Detailed Quote for Ardea Biosciences Inc. (RDEA)

close 52 Week Information

52 Week High

March 18, 2011

Close: 29.58

52 Week Low

August 22, 2011

Close: 13.15

Today

Last Price
18.765

Change $
0.235

Change %
1.24%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
18.82

High
18.96

Low
18.52

Prev Close
19.00

Last Trade
2/10/12

Volume
112.28 k

52 Wk Hi
29.58

52 Wk Low
13.15

Market Cap
504.07 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
26,862,050

EPS (TTM)
-2.10

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Ardea Biosciences Inc. (RDEA)

Sector News | Topic News

News for RDEA

Wed, Feb 08, 2012

4:00 PM

Ardea Biosciences to Present at Upcoming Investor Conferences - Marketwire

Mon, Feb 06, 2012

4:01 PM

Ardea Biosciences Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock - Marketwire

Wed, Feb 01, 2012

8:54 AM

Ardea Biosciences Prices Public Offering of Common Stock - Marketwire

Tue, Jan 31, 2012

4:01 PM

Ardea Biosciences Announces Proposed Public Offering of Common Stock - Marketwire

Mon, Dec 19, 2011

8:00 AM

Ardea Biosciences Initiates Phase 3 Clinical Development Program for Lesinurad - Marketwire

Tue, Nov 15, 2011

8:30 AM

Ardea Biosciences to Present at Upcoming Investor Conferences - Marketwire

Mon, Nov 07, 2011

8:30 AM

Ardea Biosciences Provides Additional Positive Clinical Results for Lesinurad and Initial Clinical Results for RDEA3170 at the 2011 ACR/ARHP Annual Scientific Meeting - Marketwire

Fri, Nov 04, 2011

8:30 AM

Ardea Biosciences Reports Recent Accomplishments, Important Upcoming Events and Third Quarter 2011 Financial Results - Marketwire

Wed, Oct 19, 2011

11:54 AM

Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting - Marketwire

Thu, Sep 08, 2011

8:30 AM

Ardea Biosciences to Present at Upcoming Investor Conferences - PR Newswire

Wed, Sep 07, 2011

8:30 AM

Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad - PR Newswire

More News for RDEA >>

Tags for Ardea Biosciences Inc.

Research stocks or mutual funds related to Ardea Biosciences Inc. by keywords or tags. Find companies that have a similar focus to RDEA. The keywords below have been associated to RDEA by either user submission or electronic means.

pharmaceuticals research brain cancer stage 4 pharmaceutical market types of cancer pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics pharmaceutical investment pharmaceutical research and development arthritis treatment metastatic colorectal cancer pharma marketing chemotherapy pharmaceutical software breast cancer survival rate stomach cancer pharma manufacturing pfizer pharmaceutical company kv pharmaceutical company psoriatic arthritis prostate cancer pancreatic cancer colon cancer survival rate pharmaceutical cro pharma companies pharmaceutical conferences colorectal cancer treatment pharmaceutical distributors colorectal cancer screening liver cancer biotech corporation pharmaceutical development skin cancer pharmaceutical magazine osteoarthritis treatment lung cancer articles what is cancer liver cancer symptoms Drugs pharma r&d pharmaceutical industry news symptoms lung cancer pharmaceutical manufacturing software pharmaceutical conference colorectal cancer pharmaceutical manufacturing ovarian cancer pancreatic cancer symptoms contract pharmaceutical pharmaceutical events